Evidence map›Paper›PMID 33650061›Full record

ArticleAnnals of hematology2022

The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients.

William G Dunn, Muxin S Gu, Margarete A Fabre, Jonathan Cooper, Josep F Nomdedeu, Laura Koumas, Katerina Nicolaou, Jiangxiang Chi, Paul Costeas, George S Vassiliou

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

William G DunnWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, CB2 0AW, UK.
Muxin S GuWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, CB2 0AW, UK.
Margarete A FabreWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, CB2 0AW, UK.
Jonathan CooperWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, CB2 0AW, UK.
Josep F NomdedeuWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, CB2 0AW, UK.
Laura KoumasCenter for the Study of Haematological Malignancies, Karaiskakio Foundation, Nicosia, Cyprus.
Katerina NicolaouCenter for the Study of Haematological Malignancies, Karaiskakio Foundation, Nicosia, Cyprus.
Jiangxiang ChiCenter for the Study of Haematological Malignancies, Karaiskakio Foundation, Nicosia, Cyprus.
Paul CosteasCenter for the Study of Haematological Malignancies, Karaiskakio Foundation, Nicosia, Cyprus. paul.costeas@karaiskakio.org.cy.
George S VassiliouWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, CB2 0AW, UK. gsv20@sanger.ac.uk.ORCID http://orcid.org/0000-0003-4337-8022

Funding

Cancer Research UK 23015Cancer Research UK C22324/A23015Medical Research Council MC_PC_17230Wellcome TrustWellcome Trust WT098051
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultBlood PreservationDNAHumansLeukemia, Promyelocytic, AcuteMiddle AgedOncogene Proteins, FusionWhole Genome SequencingDNAOncogene Proteins, Fusionpromyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein

Identifiers

PMID33650061
PMCPMC8742812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.